Profile data is unavailable for this security.
About the company
Molecular Partners AG is a Switzerland-based clinical-stage biotech company developing DARPin (Designed Ankyrin Repeat Proteins) a new class of custom-built protein therapeutics based on natural binding proteins that open a new dimension of multi-functionality and multi-target specificity in drug design. The Company has formed partnerships with leading pharmaceutical companies to advance DARPin therapeutics , and has compounds in various stages of clinical and preclinical development across multiple therapeutic areas.
- Revenue in CHF (TTM)6.73m
- Net income in CHF-58.53m
- Incorporated2004
- Employees168.00
- LocationMolecular Partners AGWagistrasse 14SCHLIEREN 8952SwitzerlandCHE
- Phone+41 447557700
- Fax+41 447557707
- Websitehttps://www.molecularpartners.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Xlife Sciences AG | 988.44k | 14.88m | 168.82m | 17.00 | 24.31 | 0.6173 | 6.67 | 170.79 | 1.22 | 1.22 | 0.1382 | 47.95 | 0.002 | -- | 0.2044 | 58,143.53 | 1.85 | -- | 2.33 | -- | 45.43 | -- | 938.17 | -- | -- | -- | 0.1345 | -- | -3.85 | -- | 3.96 | -- | -- | -- |
BioInvent International AB | 5.23m | -28.60m | 182.86m | 109.00 | -- | 1.74 | -- | 34.97 | -5.08 | -5.08 | 0.929 | 18.73 | 0.041 | -- | 1.29 | 550,927.90 | -22.41 | -17.50 | -23.68 | -18.64 | -- | -- | -547.02 | -131.63 | 13.34 | -- | 0.0169 | -- | -78.09 | 13.14 | -677.13 | -- | 28.17 | -- |
Vicore Pharma Holding AB | 8.91m | -18.21m | 183.43m | 26.00 | -- | 4.39 | -- | 20.58 | -2.15 | -2.15 | 1.01 | 4.38 | 0.2589 | -- | 14.41 | 4,343,459.00 | -52.89 | -58.65 | -59.34 | -65.58 | -- | -- | -204.27 | -- | -- | -- | 0.00 | -- | -- | -- | -7.81 | -- | -- | -- |
Genfit SA | 37.08m | -28.06m | 185.40m | 159.00 | -- | 2.81 | -- | 5.00 | -0.5814 | -0.5814 | 0.7681 | 1.36 | 0.1961 | 542.00 | 3.52 | 240,100.60 | -14.84 | -12.57 | -18.55 | -15.30 | 94.32 | 94.96 | -75.69 | -76.23 | 2.94 | -7.78 | 0.5080 | -- | 43.70 | 38.49 | -21.82 | -- | -3.27 | -- |
XSpray Pharma AB (publ) | 0.00 | -18.18m | 188.79m | 26.00 | -- | 4.01 | -- | -- | -7.66 | -7.66 | 0.00 | 20.00 | 0.00 | -- | -- | 0.00 | -33.92 | -18.38 | -36.11 | -19.26 | -- | -- | -- | -- | 2.24 | -- | 0.0536 | -- | -- | -- | -36.45 | -- | 2.87 | -- |
Sensorion SA | 0.00 | -21.43m | 199.05m | 50.00 | -- | 3.83 | -- | -- | -0.2063 | -0.2063 | 0.00 | 0.1779 | 0.00 | -- | -- | -- | -51.64 | -35.12 | -71.66 | -46.97 | -- | -- | -- | -- | -- | -- | 0.0794 | -- | -- | -- | 4.94 | -- | 126.45 | -- |
hVIVO PLC | 64.34m | 18.50m | 216.35m | 274.00 | 11.84 | 5.49 | 10.01 | 3.36 | 0.0234 | 0.0234 | 0.0817 | 0.0505 | 0.8327 | -- | 4.08 | 204,536.50 | 23.94 | -0.643 | 46.27 | -1.29 | -- | -- | 28.75 | -0.765 | 1.47 | -- | 0.2674 | -- | 15.61 | 35.40 | 2,176.68 | -- | 136.55 | -- |
Molecular Partners AG | 6.73m | -58.53m | 223.40m | 168.00 | -- | 1.19 | -- | 33.21 | -1.78 | -1.78 | 0.2043 | 5.13 | -- | -- | -- | 40,035.71 | -- | -11.83 | -- | -14.69 | -- | 99.28 | -870.22 | -45.30 | -- | -- | 0.0195 | -- | -96.29 | -7.43 | -152.59 | -- | -1.40 | -- |
Nanobiotix SA | 29.19m | -38.56m | 223.40m | 102.00 | -- | -- | -- | 7.65 | -1.10 | -1.10 | 0.814 | -0.0391 | 0.3912 | -- | 19.59 | 294,686.30 | -51.67 | -54.11 | -120.56 | -80.68 | -- | -- | -132.08 | -756.15 | -- | -1.98 | 1.04 | -- | -- | 203.88 | 30.40 | -- | -7.81 | -- |
4Basebio PLC | 580.87k | -8.80m | 230.05m | -- | -- | -- | -- | 396.05 | -0.6222 | -0.6222 | 0.0411 | -0.0399 | 0.0429 | 0.714 | 6.29 | -- | -64.93 | -- | -77.36 | -- | 67.19 | -- | -1,514.82 | -- | 2.06 | -26.66 | 1.05 | -- | 88.81 | -- | -48.83 | -- | -- | -- |
Ryvu Therapeutics SA | 12.61m | -21.30m | 259.51m | 230.00 | -- | 5.86 | -- | 20.58 | -4.10 | -4.10 | 2.42 | 8.45 | 0.1302 | 12.39 | 4.99 | 241,760.90 | -21.99 | -21.88 | -24.87 | -25.20 | 56.80 | -6.28 | -168.89 | -284.20 | 4.71 | -- | 0.1193 | -- | 20.32 | -9.50 | -9.94 | -- | 53.71 | -- |
Allergy Therapeutics plc | 61.14m | -57.65m | 259.91m | 635.00 | -- | 8.56 | -- | 4.25 | -0.0266 | -0.0266 | 0.017 | 0.0056 | 0.7571 | 2.21 | 4.92 | 83,870.87 | -71.39 | -11.59 | -102.10 | -15.15 | 52.54 | 70.08 | -94.29 | -11.78 | 0.9281 | -7.93 | 0.2713 | -- | -18.11 | -2.71 | -212.65 | -- | 16.41 | -- |
Bioventix PLC | 15.61m | 9.95m | 265.15m | 16.00 | 27.11 | 20.20 | 26.28 | 16.99 | 1.63 | 1.63 | 2.56 | 2.19 | 1.09 | 1.53 | 2.54 | 849,780.60 | 69.72 | 56.43 | 79.03 | 61.01 | 93.75 | 92.64 | 63.73 | 65.08 | 6.69 | -- | 0.00 | 84.49 | 9.36 | 7.93 | 9.10 | 8.13 | -37.12 | 20.03 |
Avacta Group Plc | 26.69m | -28.64m | 279.45m | 154.00 | -- | -- | -- | 10.47 | -0.0914 | -0.0914 | 0.0853 | -- | -- | -- | -- | 150,954.50 | -- | -- | -- | -- | 48.37 | -- | -107.31 | -- | -- | -0.575 | -- | -- | 140.83 | -- | 32.54 | -- | -- | -- |
Hansa Biopharma AB | 14.18m | -72.24m | 280.99m | 166.00 | -- | -- | -- | 19.81 | -16.07 | -16.07 | 3.15 | -7.10 | 0.1424 | 64.03 | 1.86 | 987,386.90 | -72.51 | -47.96 | -92.27 | -56.12 | 56.80 | 64.18 | -509.33 | -835.04 | 2.55 | -9.65 | 1.65 | -- | -13.22 | 109.06 | -36.09 | -- | -35.24 | -- |
Selvita SA | 76.47m | 14.81m | 283.03m | 387.00 | 19.12 | 3.81 | 11.07 | 3.70 | 3.56 | 3.56 | 18.37 | 17.83 | 0.553 | 9.29 | 4.70 | 398,178.30 | 10.71 | -- | 12.99 | -- | 79.66 | -- | 19.36 | -- | 1.41 | 11.34 | 0.4063 | -- | -3.48 | -- | 130.55 | -- | -- | -- |
Data as of Jul 05 2024. Currency figures normalised to Molecular Partners AG's reporting currency: Swiss Franc CHF
41.44%Per cent of shares held by top holders
Holder | Shares | % Held |
---|---|---|
BVF Partners LPas of 17 Nov 2023 | 8.70m | 23.71% |
Suvretta Capital Management LLCas of 31 Dec 2023 | 1.75m | 4.77% |
UBS Asset Management Switzerland AGas of 04 Jun 2024 | 1.13m | 3.08% |
EcoR1 Capital, LLCas of 17 Nov 2023 | 1.09m | 2.96% |
GAM Investment Management (Switzerland) AGas of 21 Nov 2022 | 1.07m | 2.91% |
Credit Suisse Asset Management (Schweiz) AGas of 29 Mar 2024 | 483.42k | 1.32% |
Union Bancaire Priv�e, UBP SAas of 31 Mar 2024 | 411.50k | 1.12% |
Z�rcher Kantonalbank (Investment Management)as of 31 May 2024 | 292.49k | 0.80% |
ACATIS Investment Kapitalverwaltungsgesellschaft mbHas of 30 Apr 2024 | 200.06k | 0.55% |
Pictet Asset Management SAas of 31 Mar 2024 | 83.92k | 0.23% |
More ▼
Data from 31 Mar 2024 - 28 Jun 2024Source: FactSet Research Systems Inc.